drugset / Trial / NCT00040300
A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate Racivir. The safety, most effective dosage, and how the body reacts to Racivir will be studied.
Timeline
- Start
- 2002-06
- Primary completion
- —
- Completion
- 2002-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EMTRICITABINE, (+/-)- | Other / unclassified | — | — |